A Phase 1/2 Study to Assess the Safety, Tolerability, Pharmacokinetics, Pharmacodynamics and Efficacy of CM24 in combination with nivolumab in adults with advanced solid tumors
![](https://researchstudies.cuanschutz.edu/Content/images/study-category-images/cancer.jpg)
Details
Age
Adult
Locations
University of Colorado Hospital
Principal Investigator
![Photograph of Alexis Leal](https://som.ucdenver.edu/FIMS/Content/faculty/25694/CU-Doctors-25694.jpg)
Alexis Leal
Study ID
Protocol Number: 23-0324
More information available at ClinicalTrials.gov: NCT04731467
Categories
Is this Study for You?
Not finding the right Study for you? Join ResearchMatch, a nation-wide registry connecting volunteers and researchers